Cumberland Pharmaceuticals (CPIX) Reports Q1 EPS of $0.11
Cumberland Pharmaceuticals (NASDAQ: CPIX) reported Q1 EPS of $0.11. Revenue for the quarter came in at $9.2 million, versus $0 reported last year.
For earnings history and earnings-related data on Cumberland Pharmaceuticals (CPIX) click here.
